Rocket Lab Corporation (RKLB) came out with a quarterly loss of $0.07 per share versus the Zacks Consensus Estimate of a loss of $0.05. This compares to a loss of $0.1 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -33.33%. A quarter ago, it was expected that this company would post a loss of $0.05 per share when it actually produced earnings of $0.01, delivering a surprise of +120%.Over the last four quarters, the company ha ...

Concentra Group (CON) came out with quarterly earnings of $0.28 per share, beating the Zacks Consensus Estimate of $0.23 per share. This compares to earnings of $0.17 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +21.74%. A quarter ago, it was expected that this provider of occupational health services would post earnings of $0.37 per share when it actually produced earnings of $0.39, delivering a surprise of +5.41%.Over the ...

Coupang, Inc. (CPNG) came out with a quarterly loss of $0.01 per share versus the Zacks Consensus Estimate of $0.02. This compares to earnings of $0.04 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -150.00%. A quarter ago, it was expected that this company would post earnings of $0.04 per share when it actually produced earnings of $0.05, delivering a surprise of +25%.Over the last four quarters, the company has surpassed co ...

Personalis (PSNL) came out with a quarterly loss of $0.26 per share versus the Zacks Consensus Estimate of a loss of $0.31. This compares to a loss of $0.23 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +16.13%. A quarter ago, it was expected that this provider of contract research and genomic information would post a loss of $0.28 per share when it actually produced a loss of $0.24, delivering a surprise of +14.29%.Over the ...

Core Viewpoint - PENN Entertainment reported quarterly earnings of $0.07 per share, exceeding the Zacks Consensus Estimate of a loss of $0.23 per share, and showing improvement from a loss of $0.44 per share a year ago, resulting in an earnings surprise of +130.32% [1] Financial Performance - The company posted revenues of $1.81 billion for the quarter ended December 2025, surpassing the Zacks Consensus Estimate by 3.18%, compared to revenues of $1.67 billion in the same quarter last year [2] - Over the last four quarters, PENN Entertainment has exceeded consensus EPS estimates three times and topped consensus revenue estimates two times [2] Stock Performance - PENN Entertainment shares have declined approximately 15% since the beginning of the year, while the S&P 500 has gained 1.5% [3] - The current Zacks Rank for PENN Entertainment is 3 (Hold), indicating that the shares are expected to perform in line with the market in the near future [6] Earnings Outlook - The current consensus EPS estimate for the upcoming quarter is -$0.02 on revenues of $1.7 billion, and for the current fiscal year, it is $0.98 on revenues of $7.09 billion [7] - The estimate revisions trend for PENN Entertainment was mixed ahead of the earnings release, which may change following the recent report [6] Industry Context - The Gaming industry, to which PENN Entertainment belongs, is currently ranked in the bottom 32% of over 250 Zacks industries, indicating potential challenges ahead [8] - Empirical research suggests a strong correlation between near-term stock movements and trends in earnings estimate revisions, which could impact PENN's stock performance [5]

Koppers (KOP) came out with quarterly earnings of $0.7 per share, beating the Zacks Consensus Estimate of $0.59 per share. This compares to earnings of $0.77 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +17.98%. A quarter ago, it was expected that this maker of chemicals, carbon compounds and wood treatment products would post earnings of $1.25 per share when it actually produced earnings of $1.21, delivering a surprise of ...

NCR Voyix (VYX) came out with quarterly earnings of $0.31 per share, beating the Zacks Consensus Estimate of $0.29 per share. This compares to a loss of $0.08 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +6.90%. A quarter ago, it was expected that this maker of ATMs and other hardware and software to handle payments would post earnings of $0.22 per share when it actually produced earnings of $0.31, delivering a surprise of ...

分组1 - Ardagh Metal Packaging S.A. reported quarterly earnings of $0.03 per share, exceeding the Zacks Consensus Estimate of $0.02 per share, with an earnings surprise of +100.00% [1] - The company achieved revenues of $1.35 billion for the quarter ended December 2025, surpassing the Zacks Consensus Estimate by 3.14%, compared to $1.2 billion in the same quarter last year [2] - The stock has increased approximately 11.7% since the beginning of the year, outperforming the S&P 500's gain of 1.5% [3] 分组2 - The current consensus EPS estimate for the upcoming quarter is $0.03 on revenues of $1.33 billion, and for the current fiscal year, it is $0.25 on revenues of $5.66 billion [7] - The Containers - Metal and Glass industry, to which Ardagh Metal Packaging belongs, is currently ranked in the bottom 26% of over 250 Zacks industries, indicating potential challenges for stock performance [8]

Core Viewpoint - Arcutis Biotherapeutics, Inc. reported quarterly earnings of $0.13 per share, significantly exceeding the Zacks Consensus Estimate of $0.03 per share, and showing an improvement from a loss of $0.09 per share a year ago, indicating a strong earnings surprise of +290.39% [1] Financial Performance - The company achieved revenues of $129.5 million for the quarter ended December 2025, surpassing the Zacks Consensus Estimate by 11.93%, and showing a substantial increase from year-ago revenues of $71.36 million [2] - Over the last four quarters, Arcutis Biotherapeutics has consistently exceeded consensus EPS estimates, achieving this four times [2] Stock Performance and Outlook - Despite the positive earnings report, Arcutis Biotherapeutics shares have declined approximately 7.1% since the beginning of the year, contrasting with the S&P 500's gain of 0.7% [3] - The company's future stock performance will largely depend on management's commentary during the earnings call and the sustainability of the recent earnings numbers [3][4] Earnings Estimates and Industry Context - The current consensus EPS estimate for the upcoming quarter is -$0.02 on revenues of $94.6 million, while for the current fiscal year, it is $0.38 on revenues of $470.02 million [7] - The Medical - Biomedical and Genetics industry, to which Arcutis belongs, is currently ranked in the top 37% of over 250 Zacks industries, indicating a favorable industry outlook that could positively influence stock performance [8]

Clear Secure (YOU) came out with quarterly earnings of $0.31 per share, in line with the Zacks Consensus Estimate . This compares to earnings of $0.9 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -1.05%. A quarter ago, it was expected that this airport security company would post earnings of $0.27 per share when it actually produced earnings of $0.29, delivering a surprise of +7.41%.Over the last four quarters, the company h ...